Maglangit, Jerol Kim G.

HRN: 06-35-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
CEFUROXIME 750MG (VIAL)
10/10/2025
10/17/2025
IV
750 Mg
Q8
Multiple Abrasions

 Indication:  Prophylaxis    Type of Infection:  Bone & Joint    Compliance to guidelines: Non-compliant To Guidelines